Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome

Summary

This study will examine the efficacy and safety of tivanisiran sodium eye drops versus vehicle after a 2-week run-in phase when dosed once daily for 3 months in subjects with signs and symptoms of dry eye disease (DED) due to Sjögren's Syndrome.

Timeline

Start

2021-05-25

Primary completion

2023-12-11

Completion

2023-12-11

Drugs

Indications